Anima Biotech updates on translation control therapeutics platform, reflects on Lilly partnership
October 27th, 2019
Anima Biotech Inc CEO Yochi Slonim caught up with Proactive at the 2019 BIO Investor Forum in San Francisco.
Slonim updated investors on its Translation Control Therapeutics platform and reflected on the company's partnership with Eli Lilly and Company.